Parameter | Day one | Day two | Normal values |
---|---|---|---|
Pleural effusion (% of patients) | 45% | 45% | Â |
Pericardial effusion (% of patients) | 15% | 15% | Â |
Disturbed myocardial relaxation (non-survivors of these patients), (% of patients) | 20% (50%) | 20% (50%) | Â |
Chest Tube, (% of patients) | 20% | 20% | Â |
Arrhythmia, (% of patients) | 15% | 15% | Â |
Wall movement disorder, (% of patients) | 25% | 25% | Â |
Aortic valve regurgitation, (% of patients) | Â | Â | Â |
- minimal/Grade 1 - Grade 2 | 5% 0% | 5% 0% | Â |
Mitral valve regurgitation, (% of patients) - Minimal/Grade 1 - Grade 2 | 50% 0% | 55% 10% | Â |
Tricuspid valve regurgitation, (% of patients) - Minimal/Grade 1 - Grade 2 | 30% 10% | 45% 15% | Â |
EF [%] | 61 ± 9.1 | 62 ± 9.6 | > 60 |
LVEDD [mm] | 48 ± 8.2 | 48 ± 6.9 | 36–55 |
IVS/LVPW [mm] | 1.3 ± 0.3 | 1.1 ± 0.2 | IVS ≤ 12 mm/ LVPW ≤ 12 mm |
TAPSE [mm] | 24 ± 3.7 | 28 ± 6.8 | > 17 |
RVEDD [mm] | 25 ± 7.2 | 26 ± 5 | < 30 |
E/E’ | 7.3 ± 2.6 | 6.8 ± 2.7 | < 8 |
E/A | 1.2 ± 0.4 | 1.4 ± 0.5 | 1–2 |
sPAP [mmHg] | 32 ± 14 | 25 ± 12 | < 36 |